Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Gain Therapeutics, Inc. unveiled a multi-target cancer-focused collaboration with Zentalis Pharmaceuticals on 20 April that will initiate the...








